{"symbol":"GILD","fiscalQuarter":"Q3-2012","reportDate":"2012-10-23","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q3-2012","postBrief":{"headline":"Gilead Sciences Beats on EPS, Stock Reaction Not Available","keyNumbers":[{"metric":"EPS","actual":"$1.00","expected":"N/A","surprise":"+11.48%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management highlighted ongoing research and development efforts.","They emphasized the importance of maintaining a strong pipeline.","No specific guidance was provided for future quarters."],"summary":"Management remains focused on innovation and pipeline development. They did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Gilead Sciences reported better-than-expected earnings per share, indicating strong performance in certain areas. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is not available, which makes it difficult to gauge investor sentiment following the report.","metaDescription":"Gilead Sciences (GILD) Q3 2012 earnings: EPS beat by 11.48%. Stock reaction not available. Full breakdown."}}